about
Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current AntiepilepticSafety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute MigraineTo Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic MigraineNon-invasive Vagus Nerve Stimulation for the Prevention of MigrainesXERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain TumorsWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerInpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure PatternALK21-025: Vivitrol's Cost and Treatment Outcomes RegistryAlzheimer's Disease Neuroimaging Initiative 2
P6153
Q61937061-15828DE8-6E02-471B-A05A-DFFC1F6B0028Q61957021-ABF9F165-F344-4947-A520-C7DA6F9E8714Q62030770-439F2D7B-F4B3-4CEE-AE76-A38B9F6D02B8Q62040757-ECB7D90E-FFA9-45DD-BA25-AB5DAA32EBADQ62110271-DDAA79DE-8FA8-480B-AC86-37A9C906FB0EQ62111080-B2C609BA-B6CF-43CA-830D-08697806DC76Q62812014-EFE300EC-AC2F-4AF3-8EAE-510CBB725203Q63321817-C1138746-6F03-4378-8E9F-8ADE46FCC7F8Q63341040-4EBB8BB8-C8C5-4760-82DA-DE88B33CE890
P6153
description
US-amerikanische Organisation
@de
organisatie uit Verenigde Staten van Amerika
@nl
other organization in Amherst, United States
@en
منظمة في أمهرست، الولايات المتحدة
@ar
name
Dent Neurologic Institute
@en
type
label
Dent Neurologic Institute
@en
prefLabel
Dent Neurologic Institute
@en
P131
P2002
dentinstitute
P2427
grid.417854.b
P31
P571
1962-01-01T00:00:00Z
P625
Point (-78.786715 42.979423)